Pfizer had “greater initial effectiveness” but saw “faster declines in protection against high viral burden and symptomatic infection.”
Read full article on Tech2
AstraZeneca’s vaccine effectiveness against COIVD-19 lasts longer than Pfizer’s finds study
- Ransomware attacks fewer but more aggressive: What to do
- Dell warns of “incident” that may have leaked customers’ personal info
- US faith-based healthcare org Ascension says ‘cybersecurity event’ disrupted clinical ops
- Beware of cyber scams: How hackers tried to scam me
- A DNS Investigation of the Typhoon 2FA Phishing Kit